NLS PHARMACEUTICS LTD. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.155 USD | -3.06% |
|
+3.75% | -73.72% |
| 04-08 | Nls Pharmaceutics Ltd. Announces Resignation of Anthony S. Walsh as A Member of the Board of Directors | CI |
| 04-03 | NLS Pharmaceutics Ltd. announced that it has received $1.75 million in funding | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 7.54M | - | - | - | - | - | |
| 62.59B | - | |||||
| 41.18B | ||||||
| 40.29B | ||||||
| 27.9B | ||||||
| 26.21B |
